High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.

PURPOSE To compare the sensitivity and specificity of diffusion-weighted (DW) magnetic resonance (MR) imaging for identifying liver metastases from neuroendocrine tumor (NET) to those of T2-weighted fast spin-echo (FSE) and three-dimensional dynamic gadolinium-enhanced MR imaging, with surgical and histopathologic findings as the reference standard. MATERIALS AND METHODS This retrospective study was approved by institutional review board, and informed consent was waived. Fifty-nine patients with NETs (41 patients with 162 liver metastases, and 18 control subjects with no liver metastases) underwent MR imaging that included DW, T2-weighted FSE, and dynamic gadolinium-enhanced MR sequences. Images were retrospectively reviewed by two abdominal radiologists, independently, for the detection and characterization of liver metastases. MR findings were compared with histopathologic and intraoperative ultrasonography findings for metastasis on a lesion-by-lesion basis to determine the sensitivity of each MR sequence alone and combined. Specificity was calculated by using the control population. Interreader agreement for each MR sequence and McNemar test were also calculated. RESULTS There was excellent agreement between observers 1 and 2 for characterizing liver metastases at per-lesion analysis (κ coefficient: 0.86-1.00). DW MR was more sensitive (observer 1: sensitivity, 71.6% [116 of 162], 95% confidence interval [CI]: 64.2%, 78.0%; observer 2: sensitivity, 71.0% [115 of 162], 95% CI: 63.6%, 77.4%) than T2-weighted FSE (observer 1: sensitivity, 55.6% [90 of 162], 95% CI: 47.9%, 63.0%; observer 2: sensitivity, 55.6% [90 of 162], 95% CI: 47.9%, 63.0%) and dynamic gadolinium-enhanced MR (observer 1: sensitivity, 47.5% [77 of 162], 95% CI: 34.0%, 55.2%; observer 2: sensitivity, 48.1% [78 of 162], 95% CI: 40.6%, 55.8%) (P < .001 for both, McNemar test). The specificity of these sequences ranged from 88.9% to 100% (DW MR vs T2-weighted FSE MR: P > .99, DW MR vs dynamic gadolinium-enhanced MR: P = .61, and T2-weighted FSE MR vs dynamic gadolinium-enhanced MR: P = .61, McNemar test). CONCLUSION DW MR imaging was more sensitive for the detection and characterization of liver metastases from NETs than T2-weighted FSE and dynamic gadolinium-enhanced MR imaging and should be systematically performed.

[1]  D. Collins,et al.  Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. , 2012, The British journal of radiology.

[2]  M. Pocard,et al.  Preoperative detection of hepatic metastases: comparison of diffusion-weighted, T2-weighted fast spin echo and gadolinium-enhanced MR imaging using surgical and histopathologic findings as standard of reference. , 2011, European journal of radiology.

[3]  K. Togashi,et al.  Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases , 2010, European Radiology.

[4]  E. Hecht,et al.  Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI , 2010, European Radiology.

[5]  E. Baudin,et al.  Hepatic Metastases From Neuroendocrine Tumors With a “Thin Slice” Pathological Examination: They are Many More Than You Think … , 2010, Annals of surgery.

[6]  M. Falconi,et al.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors , 2009, Neuroendocrinology.

[7]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[8]  Sukru Mehmet Erturk,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Characterization of Focal Liver Masses: Impact of Parallel Imaging (SENSE) and b Value , 2008, Journal of computer assisted tomography.

[9]  B. Kiefer,et al.  Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. , 2008, AJR. American journal of roentgenology.

[10]  Wilhelm Horger,et al.  Black-Blood Diffusion-Weighted EPI Acquisition of the Liver with Parallel Imaging: Comparison with a Standard T2-Weighted Sequence for Detection of Focal Liver Lesions , 2008, Investigative radiology.

[11]  J. Stoker,et al.  Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. , 2007, The British journal of radiology.

[12]  J. Gurney,et al.  Diffusion‐weighted MRI (DWI) in the oncology patient: Value of breathhold DWI compared to unenhanced and gadolinium‐enhanced MRI , 2007, Journal of magnetic resonance imaging : JMRI.

[13]  S. Nawano,et al.  Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. , 2006, Radiology.

[14]  D. Santini,et al.  Endocrine pancreatic tumors: factors correlated with survival. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  J. Norton.  Surgical treatment of neuroendocrine metastases , 2005 .

[16]  M. Vatn,et al.  Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms) Part II—Specific NE Tumour Types , 2004, Acta oncologica.

[17]  K. Öberg.  Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms) , 2004 .

[18]  R. Edelman,et al.  Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. , 1994, Radiology.

[19]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[20]  R Sinkus,et al.  [Diffusion-weighted MR imaging of the liver]. , 2010, Journal de radiologie.

[21]  A. Levy,et al.  Focal Liver Lesion Detection and Characterization with Diffusion-weighted MR Imaging: Comparison with Standard Breath-hold T2-weighted Imaging , 2009 .

[22]  J. Norton.  Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases. , 2005, Best practice & research. Clinical gastroenterology.

[23]  T. de Baère,et al.  Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  T. de Baère,et al.  MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. , 2003, AJR. American journal of roentgenology.